Search Within

Gregory J Riely

  1. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (125)
  2. Journal Article (42)
  3. Guidelines (7)
  4. Editorial (1)
Groups
  1. Department of Medicine (175)
  2. Solid Tumor Oncology Division (175)
  3. Thoracic Oncology (175)
  4. GSK Faculty (76)
  5. Department of Pathology and Laboratory Medicine (72)
  6. Human Oncology and Pathogenesis Program (70)

More Groups

People
  1. Mark Kris (85)
  2. Marc Ladanyi (59)
  3. Helena Yu (35)
  4. Vincent Miller (32)
  5. Maria Arcila (25)
  6. Charles Rudin (23)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (14)
  4. 2022 (10)
  5. 2021 (7)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (157)
  2. JCO Precision Oncology (12)
  3. American Society of Clinical Oncology Educational Book (2)
  4. JCO Clinical Cancer Informatics (2)
  5. JCO Oncology Practice (1)
  6. Journal of Oncology Practice (1)
Publishers
  1. American Society of Clinical Oncology (175)

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular on/off switch
    Journal Article

    Milton, D. T.; Riely, G. J.; Pao, W.; Miller, V. A.; Kris, M. G.; Heelan, R. T.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib
    Meeting Abstract

    Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Estimation of the likelihood of epidermal growth factor receptor (EGFR) mutations based on cigarette smoking history in patients with adenocarcinoma of the lung
    Meeting Abstract

    Pham, D.; Kris, M. G.; McDonough, T.; Riely, G. J.; Venkatraman, E. S.; Pao, W.; Wilson, R. K.; Miller, V. A.; Singh, B.; Rusch, V. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC
    Meeting Abstract

    Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung
    Meeting Abstract

    Hussain, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Riely, G.; Rizvi, N.; Gomez, J. E.; Miller, V.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save